Form 4 for BSX Boston Scientific
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001225208-25-001684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | 2025-02-11 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $105.98 | -62.9K | 1.62M | -4% | -$6.67M | |
| 2025-02-13 | 2025-02-11 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +130.1K | 1.68M | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | F | D | 62,915 | $105.98 | 1,619,873 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-11 | A | A | 130,118 | $0.00 | 1,682,788 | D | — | — |